This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Glaucoma  • Articles for Residents  • Genetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Janey L. Wiggs, MD, PhD; Douglas Vollrath, MD, PhD

Arch Ophthalmol. 2001;119:1674-1678.

Objective  To determine if a patient with an interstitial deletion of chromosome 1 is hemizygous for the TIGR/MYOC gene and if that patient has glaucoma.

Methods  A patient with an interstitial deletion of chromosome 1 was clinically examined for evidence of glaucoma. DNA samples from the patient and her family were used for molecular studies to determine the boundaries of the chromosome 1 deletion using polymorphic markers located on chromosome 1q21 to 1q24. Additional markers located in the vicinity of the TIGR/MYOC gene, including 2 derived from the ends of the gene, were used to determine if it was included in the deletion.

Results  The patient and her family showed no evidence of glaucoma. Molecular analysis demonstrated that a complex deletion of the maternal copy of chromosome 1 included the entire TIGR/MYOC gene.

Conclusions  We have determined that the patient has only 1 functional copy of TIGR/MYOC. The lack of clinical evidence of glaucoma suggests that haploinsufficiency of the TIGR/MYOC protein is not the cause of early-onset glaucoma associated with mutations in TIGR/MYOC.

Clinical Relevance  Missense and nonsense mutations in the TIGR/MYOC gene have been associated with juvenile- and adult-onset primary open-angle glaucoma. Although many different mutations have been correlated with the disease, the underlying genetic mechanism (haploinsufficiency, gain of function, or a dominant negative effect) remains unknown. Information regarding the genetic mechanism responsible for TIGR/MYOC-associated glaucoma is necessary for further studies designed to develop transgenic animal models and gene-related therapy.

From the Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Mass (Dr Wiggs); and the Department of Genetics, Stanford University School of Medicine, Stanford, Calif (Dr Vollrath).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Myocilin Is a Modulator of Wnt Signaling
Kwon et al.
Mol. Cell. Biol. 2009;29:2139-2154.
ABSTRACT | FULL TEXT  

Primary Open-Angle Glaucoma
Kwon et al.
NEJM 2009;360:1113-1124.
FULL TEXT  

Effects of Timolol on MYOC, OPTN, and WDR36 RNA Levels
Rozsa et al.
Arch Ophthalmol 2008;126:86-93.
ABSTRACT | FULL TEXT  

Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure
Shepard et al.
Hum Mol Genet 2007;16:609-617.
ABSTRACT | FULL TEXT  

Genetic Etiologies of Glaucoma
Wiggs
Arch Ophthalmol 2007;125:30-37.
ABSTRACT | FULL TEXT  

Mutated Mouse and Human Myocilins Have Similar Properties and Do Not Block General Secretory Pathway
Malyukova et al.
IOVS 2006;47:206-212.
ABSTRACT | FULL TEXT  

Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture
John
IOVS 2005;46:2650-2661.
FULL TEXT  

Molecular Analysis of the Myocilin Gene in Chinese Subjects with Chronic Primary-Angle Closure Glaucoma
Aung et al.
IOVS 2005;46:1303-1306.
ABSTRACT | FULL TEXT  

Genetically Increasing Myoc Expression Supports a Necessary Pathologic Role of Abnormal Proteins in Glaucoma
Gould et al.
Mol. Cell. Biol. 2004;24:9019-9025.
ABSTRACT | FULL TEXT  

Intracellular Sequestration of Hetero-oligomers Formed by Wild-Type and Glaucoma-Causing Myocilin Mutants
Gobeil et al.
IOVS 2004;45:3560-3567.
ABSTRACT | FULL TEXT  

Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma
Liu and Vollrath
Hum Mol Genet 2004;13:1193-1204.
ABSTRACT | FULL TEXT  

Genetic dissection of myocilin glaucoma
Gong et al.
Hum Mol Genet 2004;13:R91-102.
ABSTRACT | FULL TEXT  

Mutations in the Myocilin Gene in Families With Primary Open-angle Glaucoma and Juvenile Open-angle Glaucoma
Bruttini et al.
Arch Ophthalmol 2003;121:1034-1038.
ABSTRACT | FULL TEXT  

TIGR/MYOC Gene Sequence Alterations in Individuals with and without Primary Open-Angle Glaucoma
Pang et al.
IOVS 2002;43:3231-3235.
ABSTRACT | FULL TEXT  

Optimedin: a novel olfactomedin-related protein that interacts with myocilin
Torrado et al.
Hum Mol Genet 2002;11:1291-1301.
ABSTRACT | FULL TEXT